seco EveroliMus SodiuM Salt

CAS-Nr.

Englisch Name:: seco EveroliMus SodiuM Salt

Synonyma:: seco EveroliMus SodiuM Salt;(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] RapaMycin SodiuM Salt;(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt >80%;(2S)-1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E/Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-Methoxycyclohexyl]-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-Methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarboxylic Acid SodiuM Salt;(2S)-1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-[2-hydroxy(ethoxy)-d4]-3-Methoxycyclohexyl]-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-Methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarboxylic Acid SodiuM Salt

CBNumber:: CB62620709

Summenformel:: C53H82NNaO14

Molgewicht:: 980.20625

MOL-Datei:: Mol file

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 3

seco EveroliMus SodiuM Salt Eigenschaften

Sicherheit

seco EveroliMus SodiuM Salt Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

A labelled metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).

seco EveroliMus SodiuM Salt Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

seco EveroliMus SodiuM Salt Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32344	50

(2S)-1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-[2-hydroxy(ethoxy)-d4]-3-Methoxycyclohexyl]-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-Methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarboxylic Acid SodiuM Salt
(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt >80%
(2S)-1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E/Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-Methoxycyclohexyl]-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-Methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarboxylic Acid SodiuM Salt
seco EveroliMus SodiuM Salt
(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] RapaMycin SodiuM Salt